Biond Biologics
Series BMisgav, IsraelJan 2019
Biond Biologics raised €15M in a Series B round in Jan 2019. The company is based in Misgav, Israel. Investors in the round: Financial Services, Harel Insurance Investments, Israel Biotech Fund. Data as of Nov 2026.
Amount raised
€15M
€14,847,162
Native amount
17,000,000 USD
Stage
Series B
series b
Investors
3
Provenance & confidence
High confidenceAmount
17,000,000 USD
ECB-at-date → €15M · rate 1.145 on 2018-12-31
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
Jan 2019
Round type
series b
Amount (EUR)
€15M
Other rounds
same companyThis is the company's only recorded round.